Instrument Inactif

Communiqués Science 37 Holdings, Inc.

Actions

SNCE

US8086442071

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Science 37 : Surpasses Enrollment Goals,…	12/06	PU
Science 37 : Metasite™ Undergoes Successful FDA…	13/05	PU
Science 37 : Delivers 22x Faster Enrollment than…	02/05	PU
EMed completes tender offer for all outstanding shares of Science 37	12/03	PR
SCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCE	27/02	BU
SCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCE	10/02	BU
INVESTIGATION ALERT: Halper Sadeh LLC Investigates MGRC, SNCE, VINE, CALB	06/02	PR
Shareholder Alert: Ademi LLP investigates whether Science 37 Holdings, Inc. has obtained a Fair Price in its transaction with eMed	31/01	PR
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MGRC, SNCE, VINE, CERE	29/01	PR
SNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Science 37 Holdings, Inc. Is Fair to Shareholders	29/01	BU
Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment	29/01	AQ
Science 37 : Citeline Connect Partners with Science 37	15/12	PU
Science 37 Receives Top Honors in Everest PEAK Matrix®	12/12	AQ
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	07/12	GL
Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023	05/12	GL
Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023	05/12	AQ
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	10/11	GL
Science 37 Reports Third Quarter 2023 Financial Results	07/11	GL
Science 37 to Report Third Quarter 2023 Financial Results on November 7, 2023	24/10/23	GL
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	06/10/23	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Science 37 Holdings, Inc.

Actions

SNCE

US8086442071

Communiqués

Filtres